Sayo Soda
Tochigi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study.
Journal: International journal of clinical oncology
Published: May 03, 2025
Case report of a patient with stage IV lung adenocarcinoma and uncommon/compound EGFR mutations who responded to afatinib.
Journal: Respiratory medicine case reports
Published: March 16, 2024
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Journal: Targeted oncology
Published: March 04, 2024
Corrigendum to "Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedation" [Resp. Invest. 61 (2023) 793-799].
Journal: Respiratory investigation
Published: January 31, 2024
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060.
Journal: JTO clinical and research reports
Published: November 27, 2023
Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedation.
Journal: Respiratory investigation
Published: June 14, 2023
Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study.
Journal: Thoracic cancer
Published: February 07, 2022
Changing patterns of pulmonary abnormalities in rheumatoid arthritis.
Journal: Respiratory investigation
Published: January 20, 2022
A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide.
Journal: Journal of chemotherapy (Florence, Italy)
Published: May 21, 2020
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real-world efficacy and safety in advanced/recurrent non-small cell lung carcinoma.
Journal: Thoracic cancer
Published: January 26, 2020
Last Updated: 09/26/2026